These findings elucidate the molecular mechanisms by which CDA1 plays an antifibrotic role by inhibiting the lung fibroblast-to-myofibroblast transition and downstream TGF-β/Smad3 signaling pathway in BLM-induced PF. Here, TSPYL2 is linked to pemphigus foliaceus.